ClinicalTrials.gov
public full text
Public Domain
Low-Dose Naltrexone Combined With Bupropion to Stop Smoking With Less Weight Gain
This study will test a combination of the drugs naltrexone and bupropion with weight-concerned smokers to investigate whether or not this combination of drugs improves smoking cessation quit rates and minimizes post quit weight gain.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Efficacy of Two Novel Behavioral Post-cessation Weight Gain Interventions#1089072
- Combined Bio- and Neuro- Feedback vs. Varenicline Use for Smoking Cessation#909897
- EVarQuit: Extended Pre-quit Varenicline to Assist in Quitting Smoking#865818
- Bupropion Alone or Combined With Nicotine Gum#1153800
- Comparing Smoking Treatment Programs for Lighter Smokers - 1#857995
Record · ID 845770
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive